NASDAQ
CTI BioPharma Corp. (CTIC) has a current ratio of 1.23x as of Monday, May 25, 2026. This represents a 49.57% decrease compared to its 12-month average of 2.43x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.